Kinase gene fusions in defined subsets of melanoma

黑色素瘤特定亚群中的激酶基因融合

阅读:2
作者:Jacqueline Turner ,Kasey Couts ,Jamie Sheren ,Siriwimon Saichaemchan ,Witthawat Ariyawutyakorn ,Izabela Avolio ,Ethan Cabral ,Magdelena Glogowska ,Carol Amato ,Steven Robinson ,Jennifer Hintzsche ,Allison Applegate ,Eric Seelenfreund ,Rita Gonzalez ,Keith Wells ,Stacey Bagby ,John Tentler ,Aik-Choon Tan ,Joshua Wisell ,Marileila Varella-Garcia ,William Robinson

Abstract

Genomic rearrangements resulting in activating kinase fusions have been increasingly described in a number of cancers including malignant melanoma, but their frequency in specific melanoma subtypes has not been reported. We used break-apart fluorescence in situ hybridization (FISH) to identify genomic rearrangements in tissues from 59 patients with various types of malignant melanoma including acral lentiginous, mucosal, superficial spreading, and nodular. We identified four genomic rearrangements involving the genes BRAF, RET, and ROS1. Of these, three were confirmed by Immunohistochemistry (IHC) or sequencing and one was found to be an ARMC10-BRAF fusion that has not been previously reported in melanoma. These fusions occurred in different subtypes of melanoma but all in tumors lacking known driver mutations. Our data suggest gene fusions are more common than previously thought and should be further explored particularly in melanomas lacking known driver mutations. Keywords: acral; kinase; melanoma; pan-negative; rearrangement.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。